These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6707579)

  • 1. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose.
    Hind CR; Collins PM; Renn D; Cook RB; Caspi D; Baltz ML; Pepys MB
    J Exp Med; 1984 Apr; 159(4):1058-69. PubMed ID: 6707579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria.
    Hind CR; Collins PM; Baltz ML; Pepys MB
    Biochem J; 1985 Jan; 225(1):107-11. PubMed ID: 3883985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-dependent aggregation of human serum amyloid P component. Inhibition by the cyclic 4,6-pyruvate acetal of galactose.
    Hind CR; Collins PM; Pepys MB
    Biochim Biophys Acta; 1984 Nov; 802(1):148-50. PubMed ID: 6435685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component.
    de Beer FC; Baltz ML; Holford S; Feinstein A; Pepys MB
    J Exp Med; 1981 Oct; 154(4):1134-9. PubMed ID: 6793685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that serum amyloid P component binds to mannose-terminated sequences of polysaccharides and glycoproteins.
    Kubak BM; Potempa LA; Anderson B; Mahklouf S; Venegas M; Gewurz H; Gewurz AT
    Mol Immunol; 1988 Sep; 25(9):851-8. PubMed ID: 3211159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits.
    Hind CR; Collins PM; Caspi D; Baltz ML; Pepys MB
    Lancet; 1984 Aug; 2(8399):376-8. PubMed ID: 6147456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of guinea-pig serum amyloid P component.
    Maudsley S; Hind CR; Munn EA; Buttress N; Pepys MB
    Immunology; 1986 Oct; 59(2):317-22. PubMed ID: 3770806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-dependent aggregation of human serum amyloid P component.
    Baltz ML; De Beer FC; Feinstein A; Pepys MB
    Biochim Biophys Acta; 1982 Feb; 701(2):229-36. PubMed ID: 7074110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid p component does not circulate in complex with C4-binding protein, fibronectin or any other major protein ligand.
    Sen JW; Heegaard NH
    Scand J Immunol; 2002 Jul; 56(1):85-93. PubMed ID: 12100475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase.
    Sørensen IJ; Nielsen EH; Andersen O; Danielsen B; Svehag SE
    Scand J Immunol; 1996 Oct; 44(4):401-7. PubMed ID: 8845035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose.
    Thompson D; Pepys MB; Tickle I; Wood S
    J Mol Biol; 2002 Jul; 320(5):1081-6. PubMed ID: 12126626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.
    García de Frutos P; Dahlbäck B
    J Immunol; 1994 Mar; 152(5):2430-7. PubMed ID: 8133054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding specificity of mouse serum amyloid P-component for fibronectin.
    Tseng J; Mortensen RF
    Immunol Invest; 1986 Dec; 15(8):749-61. PubMed ID: 3596677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of serum amyloid P-component (SAP) by amyloid fibrils.
    Pepys MB; Dyck RF; de Beer FC; Skinner M; Cohen AS
    Clin Exp Immunol; 1979 Nov; 38(2):284-93. PubMed ID: 118839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and serum amyloid P component in the plaice (Pleuronectes platessa L.), a marine teleost, are homologous with their human counterparts.
    Pepys MB; De Beer FC; Milstein CP; March JF; Feinstein A; Butress N; Clamp JR; Taylor J; Bruton C; Fletcher TC
    Biochim Biophys Acta; 1982 May; 704(1):123-33. PubMed ID: 7093286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
    Maeda S
    Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.
    Tennent GA; Lovat LB; Pepys MB
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4299-303. PubMed ID: 7753801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agglutination of complement-coated erythrocytes by serum amyloid P-component.
    Hutchcraft CL; Gewurz H; Hansen B; Dyck RF; Pepys MB
    J Immunol; 1981 Mar; 126(3):1217-9. PubMed ID: 7462631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperone properties of serum amyloid P component.
    Coker AR; Purvis A; Baker D; Pepys MB; Wood SP
    FEBS Lett; 2000 May; 473(2):199-202. PubMed ID: 10812074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human serum amyloid P component is a single uncomplexed pentamer in whole serum.
    Hutchinson WL; Hohenester E; Pepys MB
    Mol Med; 2000 Jun; 6(6):482-93. PubMed ID: 10972085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.